These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1240 related articles for article (PubMed ID: 22677369)

  • 21. Dosimetric effects of the acuros XB and anisotropic analytical algorithm on volumetric modulated arc therapy planning for prostate cancer using an endorectal balloon.
    Koo T; Chung JB; Eom KY; Seok JY; Kim IA; Kim JS
    Radiat Oncol; 2015 Feb; 10():48. PubMed ID: 25890071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.
    Wolff D; Stieler F; Welzel G; Lorenz F; Abo-Madyan Y; Mai S; Herskind C; Polednik M; Steil V; Wenz F; Lohr F
    Radiother Oncol; 2009 Nov; 93(2):226-33. PubMed ID: 19765846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automated volumetric modulated arc therapy planning for whole pelvic prostate radiotherapy.
    Buschmann M; Sharfo AWM; Penninkhof J; Seppenwoolde Y; Goldner G; Georg D; Breedveld S; Heijmen BJM
    Strahlenther Onkol; 2018 Apr; 194(4):333-342. PubMed ID: 29270648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variations in dosimetric distribution and plan complexity with collimator angles in hypofractionated volumetric arc radiotherapy for treating prostate cancer.
    Li MH; Huang SF; Chang CC; Lin JC; Tsai JT
    J Appl Clin Med Phys; 2018 Mar; 19(2):93-102. PubMed ID: 29322625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.
    Chera BS; Vargas C; Morris CG; Louis D; Flampouri S; Yeung D; Duvvuri S; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):994-1002. PubMed ID: 19619961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does helical tomotherapy improve dose conformity and normal tissue sparing compared to conventional IMRT? A dosimetric comparison in high risk prostate cancer.
    Murthy V; Mallik S; Master Z; Sharma PK; Mahantshetty U; Shrivastava SK
    Technol Cancer Res Treat; 2011 Apr; 10(2):179-85. PubMed ID: 21381796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric comparison of TomoDirect, helical tomotherapy, VMAT, and ff-IMRT for upper thoracic esophageal carcinoma.
    Zhang Y; Wang H; Huang X; Zhang Q; Ren R; Sun R; Zheng Z; Dong S; Zheng A
    Med Dosim; 2019 Summer; 44(2):167-172. PubMed ID: 29950277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
    Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
    J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
    Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer.
    Mellon EA; Javedan K; Strom TJ; Moros EG; Biagioli MC; Fernandez DC; Wasserman SG; Wilder RB
    Pract Radiat Oncol; 2015; 5(1):11-5. PubMed ID: 25413432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer.
    Akino Y; Koizumi M; Sumida I; Takahashi Y; Ogata T; Ota S; Isohashi F; Konishi K; Yoshioka Y
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1715-22. PubMed ID: 21620584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SmartArc-based volumetric modulated arc therapy for oropharyngeal cancer: a dosimetric comparison with both intensity-modulated radiation therapy and helical tomotherapy.
    Clemente S; Wu B; Sanguineti G; Fusco V; Ricchetti F; Wong J; McNutt T
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1248-55. PubMed ID: 20947268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dosimetric comparison between helical tomotherapy and step-and-shoot intensity modulated radiation therapy for endometrial carcinoma].
    Yang RJ; Xu SP; Jiang WJ; Wang JJ; Xie CB
    Ai Zheng; 2009 Nov; 28(11):1121-6. PubMed ID: 19895729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
    Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
    Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
    Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
    J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dosimetric analysis comparing treatment of low-risk prostate cancer with TomoTherapy versus static field intensity modulated radiation therapy.
    Shah AP; Chen SS; Strauss JB; Kirk MC; Coleman JL; Coon AB; Miller C; Dickler A
    Am J Clin Oncol; 2009 Oct; 32(5):460-6. PubMed ID: 19564784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
    Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
    Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients.
    Deng X; Han C; Chen S; Xie C; Yi J; Zhou Y; Zheng X; Deng Z; Jin X
    J Appl Clin Med Phys; 2017 Jan; 18(1):25-31. PubMed ID: 28291936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer.
    Hysing LB; Skorpen TN; Alber M; Fjellsbø LB; Helle SI; Muren LP
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1496-503. PubMed ID: 18538493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.